Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Methotrexate effectively managed SAPHO syndrome symptoms when other treatments failed.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

SM04755 may be an effective topical treatment for psoriasis.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.